Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06415942 · ClinicalTrials.gov registry record · NA

Assessing the Maternal Outcome Monitoring Systems

A NA study of Maternal Death and Maternal Complication of Pregnancy, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT06415942 is a NA study of Maternal Death and Maternal Complication of Pregnancy that is actively recruiting participants, run by Columbia University. The registered enrollment target is 80 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06415942, a NA study of Maternal Death and Maternal Complication of Pregnancy, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

Pregnancy-related death is a growing public health issues, which are of particular concern to minority groups, including African-Americans and Spanish-speaking Latinas. Our proposal aims to improve a patient's ability to detect warning signs of pregnancy related death and seek medical care.

Interventions

  • OTHER Maternal Outcome Monitoring and Support system

Study Locations (2)

New York

  • NewYork-Presbyterian Columbia University Irving Medical Center - New York
  • NewYork-Prebyterian/Weill Cornell Medical Center - New York

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-12-11
Est. Completion 2027-01-31
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT06415942

The ClinicalTrials.gov registry entry for NCT06415942 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Maternal Death appearing as the primary indexed condition, and to 1 intervention - of which Maternal Outcome Monitoring and Support system is the first listed.

NCT06415942 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06415942 about?

NCT06415942 is a clinical study titled "Assessing the Maternal Outcome Monitoring Systems". Pregnancy-related death is a growing public health issues, which are of particular concern to minority groups, including African-Americans and Spanish-speaking Latinas. Our proposal aims to improve a patient's ability to detect warning signs of pregnancy related death and seek medical care.

What is the current status of trial NCT06415942?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-12-11. Estimated completion is 2027-01-31.

What conditions does trial NCT06415942 study?

This clinical trial studies the following conditions: Maternal Death, Maternal Complication of Pregnancy.

What interventions are being tested in trial NCT06415942?

The interventions under investigation include: Maternal Outcome Monitoring and Support system (OTHER).

Who is sponsoring clinical trial NCT06415942?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06415942 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Maternal Death

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.